First Nebraska Trust Co Acquires New Shares in Danaher Corporation $DHR

First Nebraska Trust Co acquired a new position in shares of Danaher Corporation (NYSE:DHR) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 72,559 shares of the conglomerate’s stock, valued at approximately $16,075,000. Danaher comprises about 1.3% of First Nebraska Trust Co’s investment portfolio, making the stock its 18th biggest position.

Other institutional investors also recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in Danaher in the second quarter valued at $10,492,520,000. Wellington Management Group LLP increased its position in shares of Danaher by 10.4% in the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after buying an additional 1,542,310 shares in the last quarter. Jupiter Topco LLC acquired a new position in shares of Danaher during the 2nd quarter worth $1,456,317,000. Generation Investment Management LLP acquired a new position in shares of Danaher during the 2nd quarter worth $1,287,949,000. Finally, Bank of America Corp DE acquired a new position in shares of Danaher during the 2nd quarter worth $993,846,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Up 0.9%

Shares of NYSE DHR opened at $229.99 on Wednesday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The firm’s 50 day moving average price is $219.38 and its 200 day moving average price is $201.70. The firm has a market cap of $161.80 billion, a P/E ratio of 37.64, a price-to-earnings-growth ratio of 2.86 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $1.92 by $0.19. The firm had revenue of $6.55 billion during the quarter, compared to analysts’ expectations of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. Danaher’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same period in the previous year, the company earned $1.89 EPS. As a group, sell-side analysts anticipate that Danaher Corporation will post 8.59 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were issued a dividend of $0.40 per share. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s dividend payout ratio (DPR) is 26.19%.

Insider Activity

In other news, CAO Christopher Bouda sold 7,598 shares of Danaher stock in a transaction on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total value of $1,782,186.88. Following the completion of the sale, the chief accounting officer owned 9,107 shares of the company’s stock, valued at $2,136,137.92. The trade was a 45.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 10.80% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms recently commented on DHR. Morgan Stanley boosted their price objective on shares of Danaher from $220.00 to $240.00 and gave the stock an “overweight” rating in a research report on Monday, October 12th. TD Cowen raised their target price on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, October 22nd. Weiss Ratings upgraded shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. JPMorgan Chase & Co. lifted their target price on shares of Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a research report on Thursday, October 22nd. Finally, UBS Group reaffirmed a “buy” rating and issued a $260.00 price target on shares of Danaher in a report on Thursday, October 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $242.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.